Forgot your password? 
New user? Document Actions
Top Story ... |
Covance Intending but Not Hurrying to Expand in China |
Covance has given more details of its plans for China, with CEO Joe Herring suggesting there will not be a big shift in work from the US and Europe to the nation.
This idea is underpinned by Herring’s belief that there will be "large equilibrium in labour rates", which would reduce the appeal of operating in China ... [Read More]Featured Article |
Chinese Outsourcing Nears Full Service
February 02, 2009 - Jim J. Zhang, Ph.D.
The Chinese outsourcing industry is playing an increasingly important role in today's global pharmaceutical arena. The capabilities of this industry are limited at present, and no China-based service providers are currently able to provide totally integrated service ...
[Read More]
Latest News |
CROChina is Now Part of CROAsia - an Asia Pharma-Outsourcing Portal
May 28, 2009 - CROChina
We are now pleased to announce that we have launched a brand-new, multifunctional media platform - www.CROAsia.net, and we are in the progress of integrating CROChina.com into CROAsia.net ... ... [Read More]
Sundia MediTech and Xcovery Announce Big Success in Drug Discovery
February 10, 2009
Sundia MediTech, a CRO company based in Shanghai, China and Xcovery, a company based in Florida, U.S.A. jointly announced their 2 year collaborative success in new drug discovery at IBC's BioProcess International Conference yesterday in San Diego, USA ... [Read More]
WuXi Adopts H-Cube for Drug Discovery
January 06, 2009
WuXi AppTec is to use ThalesNano's H-Cube for laboratory-based hydrogenation, which the CRO believes offers advantages in drug discovery over traditional batch processes. By using the H-Cube WuXi joins illustrious company, with ThalesNano claiming that the world's top 20 pharmaceutical companies ... [Read More]
PPD Acquires Merck's Vaccine Testing Lab
January 05, 2009
PPD, Inc. (Nasdaq: PPDI) today announced it has entered into a strategic collaboration with Merck & Co., Inc., involving vaccine testing and assay development. Under the agreements, PPD purchased Merck's 130,000 square-foot vaccine testing laboratory and related equipment in Wayne, Penn. ... [Read More]
WuXi PharmaTech Shanghai Rodent Facility Awarded AAALAC Accreditation
December 18, 2008
WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its rodent facility in Shanghai has received accreditation ... [Read More]
PPD To Expand Central Lab into Singapore
December 17, 2008
PPD, Inc. plans to expand its global central lab services into Singapore in response to growing demand in Southeast Asia. The lab is expected to begin operations in mid-2009 and will provide biopharmaceutical clients with a "comprehensive range of highly customized lab services," ... [Read More]
PRA Partners with Frontage Labs for Testing Services
December 03, 2008
PRA International has entered an agreement with Frontage Laboratories, Inc., enabling PRA Early Development Services' U.S. Clinical Pharmacology Center to offer full analytical lab testing services to its Phase I - IV trial services in North America ... [Read More]
China's Kaifeng Pharmaceutical Expands Footprint in International API Markets
December 02, 2008
China's Kaifeng Pharmaceutical (Group), a subsidiary of Henan province-based Furen Medicines Group, is moving forward with its plan to grab a larger share of the global pharmaceutical market by seeking international certification and expanding its API ... [Read More]
WuXi PharmaTech Discontinues Bio-Manufacturing in US
December 02, 2008
WuXi PharmaTech (Cayman) Inc. today announced it will dedicate its Philadelphia facility to the Company's expanding biologics testing, cell banking and cell therapy services, and as of December 31, 2008, WuXi will discontinue its U.S. biologics manufacturing operations ... [Read More]
Tigermed Builds Up Phase I CRO Services
December 01, 2008
Tigermed Consulting Co., Ltd., a CRO with a clinical trial focus, has established a subsidiary, Hunan Tigermed Xiangya Drug R&D Ltd. Tigermed Xiangya, a collaboration with Central South University (CSU), will increase Tigermed¡¯s services in pre-clinical drug studies ... [Read More]
